Objective: To determine the incidence, diagnostic features, and periop
erative predictors of acute cholecystitis after cardiovascular surgery
. Design: Inception cohort study. Setting: A tertiary care 54-bed card
iothoracic ICU, Patients: All patients admitted to an ICU after cardio
vascular surgery during a 42-month period. Intervention: Collection of
relevant preoperative, operative, and ICU data From a database and me
dical charts. Primary outcome: Postoperative acute cholecystitis (AC),
Results Out of 11,330 admissions, 876 patients stared in the ICU more
than 7 days and 30 of them (3%) developed postoperative AC, AC was di
agnosed a median of 26 days after cardiovascular surgery (interquartil
e range, 11 to 41 days). All patients with AC developed at least two c
riteria of the systemic inflammatory response syndrome (SIRS), and 16
of them (53%) were vasopressor-dependent on the day of diagnosis. Tren
ds in biochemical testing of liver function were not diagnostic for AC
, Death occurred in seven of 17 patients (41%) who underwent cholecyst
ectomy, three of nine patients (33%) treated with percutaneous cholecy
stostomy, and one of four patients (25%) treated conservatively (p=not
significant). Specific earlier predictors of AC were arterial vascula
r disease, preoperative oxygen delivery less than 430 mL/min . m(2,) l
onger times on cardiopulmonary bypass, surgical re-exploration, ICU co
urse complicated by cardiac arrhythmia, mechanical ventilation greater
than or equal to 3 days, bacteremia, and nosocomial infections. Concl
usion: The incidence of AC is low after cardiovascular surgery. Althou
gh SIRS and hemodynamic instability were common at the time of diagnos
is, the delayed occurrence and lack of specificity of these features f
or AC limited their utility for early diagnosis. Specific predictors o
f AC should be sought in the ICU setting to identify; patients who are
at risk for AC after cardiovascular surgery. When identified, such pr
edictors can prompt earlier diagnosis and treatment. Further evaluatio
n of the selection criteria for different treatment options is needed
in order to decrease the morbidity and mortality associated with AC.